RE: Abject share price performance28 Sep 2022 12:50
I did a bit of digging, and there is a trial in Vienna and a Study at Rochester University USA, both running in parallel. It is the Rochester study that is being used as the test for the Angle labs. In the RNS announcing the study it states patient recruitment is beyond the control of AGL. To be fair to AN he was also told by the FDA that assessment would take 150 days, but was it his fault it took longer?